INFU earnings

Full Year 2025 vs. Full Year 2024: Seventh Consecutive Year of Record Net Revenues: $143.4 million, Up 6% Net Income Increased to: $6.6 million, Up 183% Record Adjusted EBITDA (non-GAAP): $31.5 million, Up 24% Record Operating Cash Flow of $24.4 million, Up 19%: InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter Overview: Net revenues totaled $36.2 million, an increase of 7% vs. prior year. Patient Services

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, February 24, 2026 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live web

Record Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% Stock Repurchases totaled $2.2 million during third quarter Reaffirms Full-Year 2025 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarte

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2025 financial results on Tuesday, November 4, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, November 4, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in t

Record Net Revenues of $36.0 million Representing 7% Growth from the Prior Year Net income of $2.6 million, up 262% Adjusted EBITDA (non-GAAP) of $8.0 million, up 32% Adjusted EBITDA (non-GAAP) margin expanded by 4.3% to 22.3% Year-to-Date Net Operating Cash Flow of $8.8 million, up 227% Stock Repurchases totaled $3.5 million InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Overview: Net revenues totaled $36.0

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2025 financial results on Tuesday, August 5, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, August 5, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the

Record Net Revenues of $34.7 million Representing 9% Growth from the Prior Year Net loss of $0.3 million Adjusted EBITDA (non-GAAP) of $6.3 million, up 64% Adjusted EBITDA (non-GAAP) margin expanded by 6.2% to 18.2% Stock Repurchases totaled approximately $3.0 million InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2025. 2025 First Quarter Overview: Net revenues totaled $34.7 million, an increase of 9% vs. prior year. Patient Services net rev

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2025 financial results on Thursday, May 8, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, May 8, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investor

Full Year 2024 vs. Full Year 2023: Record Net Revenues: $134.9 million, a 7% increase Patient Services Revenue: $80.4 million - Device Solutions Revenue: $54.5 million, increases of 5% and 11% Adjusted EBITDA (non-GAAP): $25.3 million, a 13% increase Record Operating Cash Flow: $20.5 million, an 82% increase InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter Overview: Net revenues totaled $33.8 million, an in

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, March 4, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, wh

Record Net Revenues of $35.3 million Representing 11% Growth from the Prior Year Net income of $1.8 million, an increase of 162% Adjusted EBITDA (non-GAAP) margin expanded by 2.8% to 22% Reaffirms Full-Year 2024 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2024. 2024 Third Quarter Overview: Net revenues totaled $35.3 million, an increase of 11% vs. prior year. Patient Services net revenue was $20.8 million, an increase of 8% vs

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2024 financial results on Thursday, November 7, 2024, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, November 7, 2024 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in th

Record Net Revenues of $33.7 million Representing 6% Growth from the Prior Year Reaffirms Full-Year 2024 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2024. 2024 Second Quarter Overview: Net revenues totaled $33.7 million, an increase of 6% vs. prior year. Patient Services net revenue was $20.2 million, an increase of 5% vs. prior year. Device Solutions net revenue was $13.5 million, an increase of 8% vs. prior year. Gros

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, August 8, 2024 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in th

Record Net Revenues of $32.0 million Representing 5% Growth from the Prior Year Gross Profit increased 10% - Gross Margin of 51.5%, an increase of 2.3% InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2024. 2024 First Quarter Overview: Net revenues totaled $32.0 million, an increase of 5% vs. prior year. Patient Services net revenue was $18.6 million, a decrease of 1% vs. prior year. Device Solutions net revenue was $13.4 million, an incre

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2024 financial results on Thursday, May 9, 2024, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, May 9, 2024 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (800) 285-6670 or (713) 481-1320, or listen via a live webcast, which is available in the Inves

Full Year 2023 vs. Full Year 2022: Record Net Revenues: $125.8 million, a 14% increase Patient Services Revenue: $76.5 million - Device Solutions Revenue: $49.2 million, increases of 11% and 20% Adjusted EBITDA (non-GAAP): $22.4 million, an 8% increase Five Year CAGR: Net Revenues 13% and Adjusted EBITDA 10% InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter Overview: Net revenues totaled $31.8 million, an

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2023 financial results on Thursday, March 14, 2024, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, March 14, 2024 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast

Record Net Revenues of $31.9 million Representing 17% Growth from the Prior Year Operating Income Increased 80% - Net Income Increased 56% - Adjusted EBITDA Increased 11% Raising Full Year 2023 Net Revenue Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2023. 2023 Third Quarter Overview: Net revenues totaled $31.9 million, an increase of 17% vs. prior year. Patient Services (formerly Integrated Therapy Services ("ITS")) net re

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2023 financial results on Tuesday, November 7, 2023, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, November 7, 2023 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in t

Record Net Revenues of $31.7 million Representing 17% Growth From the Prior Year InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2023. 2023 Second Quarter Overview: Net revenues totaled $31.7 million, an increase of 17% vs. prior year. Patient Services (formerly Integrated Therapy Services ("ITS")) net revenue was $19.3 million, an increase of 12% vs. prior year. Device Solutions (formerly Durable Medical Equipment Services ("DME Services")

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2023 financial results on Thursday, August 3, 2023, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, August 3, 2023 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in th

Record Net Revenues of $30.4 million Representing 13% Growth From the Prior Year InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2023. 2023 First Quarter Overview: Net revenues totaled $30.4 million, an increase of 13% vs. prior year. Integrated Therapy Services ("ITS") net revenue was $18.8 million, an increase of 13% vs. prior year. Durable Medical Equipment Services ("DME Services") net revenue was $11.6 million, an increase of 15% vs.

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2023 financial results on Thursday, May 4, 2023, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, May 4, 2023 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Inves

Full Year 2022 vs. Full Year 2021: Record Net Revenues: $109.9 million, a 7% increase ITS Revenue: $68.9 million - DME Revenue: $41.0 million, increases of 5% and 12% Adjusted EBITDA: $20.7 million 2023 Full Year Guidance - Revenue Growth 8% to 10%; Adjusted EBITDA Margin 19% plus InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter Overview: Net revenues totaled $28.8 million, an increase of 9% vs. prior year.

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2022 financial results on Wednesday, March 15, 2023, before the market opens. The Company will also conduct a conference call for all interested parties on Wednesday, March 15, 2023 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast,

Record Net Revenues of $27.3 million and Record ITS revenues of $17.4 million Operating Income increased $1.3 million and Net Income increased $0.9 million InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2022. Recent Events: November 3, 2022: Formed Wound Therapy Partnership with Sanara MedTech – delivering a complete wound care solution to improve patient outcomes and lower the cost of care. November 3, 2022: Signed distribution agreement w

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2022 financial results on Tuesday, November 8, 2022, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, November 8, 2022 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the

Net Revenues increased 9% to $27 million; ITS revenues increased 6% and DME revenues increased 15% InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2022. 2022 Second Quarter Overview: Net revenues totaled $27.0 million, an increase of 9% vs. prior year. Integrated Therapy Services ("ITS") net revenue was $17.2 million, an increase of 6% vs. prior year. Durable Medical Equipment Services ("DME Services") net revenue was $9.8 million, an increase

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue second quarter 2022 financial results on Thursday, August 4, 2022, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, August 4, 2022 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the I

Signed 3-year Master Service Agreement with Leading Global Medical Technology and Diagnostic Company – Estimated Potential Annual Revenue of $10 Million to $12 Million Revenue Growth of 9% - Driven by 18% Growth in DME and 5% in ITS Strong Operating Cash Flow Growth of 54% Repurchased Approximately $4 Million of Common Stock During the First Quarter under the $20 Million Stock Repurchase Program InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the first quarter ended March 31, 2022

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue first quarter 2022 financial results on Thursday, May 5, 2022, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, May 5, 2022 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (888) 567-1603 or (862) 298-0702, or listen via a live webcast, which is available in the Investor

Full Year 2021 vs. Full Year 2020: Net Revenues: $102.4 million, a 5% increase Net Income: $1.4 million, Adjusted EBITDA: $24.0 million InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported preliminary financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter Overview: Net revenues totaled $26.5 million, an increase of 7.3% vs. prior year. Gross profit was $15.3 million, an increase of 2.1% vs. prior year. Gross margin was 57.7%, a decrease of 2.9% vs. prior year. N

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2021 financial results on Thursday, February 10, 2022, before the market opens. The Company will also conduct a conference call for all interested parties on Thursday, February 10, 2022 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webc

Selected as Supplier of Infusion Pump Biomedical Services for Leading Global Medical Technology and Diagnostic Equipment Company Worth Expected $14 Million to $15 Million in Annual Revenue Potential Received Pain Management Service Agreement with Leading U.S. Healthcare Provider Reaffirms Full Year 2021 Guidance InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2021. 2021 Third Quarter Overview: Net revenues totaled $26.6 million, an increase

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2021 financial results on Monday, November 15, 2021, before the market opens. The Company will also conduct a conference call for all interested parties on Monday, November 15, 2021 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the

Launched Fourth ITS Therapy - LymphedemaAnnounced $20 million Stock Repurchase ProgramUpdates Guidance for 2021 ROCHESTER HILLS, Michigan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the second quarter ended June 30, 2021. 2021 Second Quarter Overview: Net revenues totaled $24.8 million, a decrease of 4% vs. prior year and up 2% sequentially. ITS net revenue was $16.3 million, an increase of 5% vs. prior year.DME Services net revenue was $8.5

ROCHESTER HILLS, Michigan, Aug. 05, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced that it will issue second quarter 2021 financial results on Thursday, August 12, 2021, before the market opens. The Company will also conduct a conference call for all interested investors on Thursday, August 12, 2021, at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which i